We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdComm Votes Asthma Combo Up for Adults, Down for Children
AdComm Votes Asthma Combo Up for Adults, Down for Children
Members of the FDA’s Pulmonary-Allergy Drugs Advisory Committee agreed 16-1 that the first-ever inhaled combination of two already-approved asthma drugs would benefit adults, but they declined to recommend it for teens (9-8) and children age four to 12 (16-1).